ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Budapest, Budapest, HUN:

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Budapest, Hungary and 215 other locations

The purpose of this study is to assess the antitumor efficacy of single-agent brentuximab vedotin 1.8 mg/kg administered intravenously (IV) every 3 w...

Active, not recruiting
Lymphoma
Drug: Brentuximab vedotin

Phase 4

Takeda
Takeda

Budapest, Hungary and 39 other locations

The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...

Enrolling
Relapsed Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
Drug: Gemcitabine
Drug: Rituximab

Phase 3

ADC Therapeutics

Budapest, Hungary and 143 other locations

The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...

Active, not recruiting
Lymphoma,Non-Hodgkin
Drug: Placebo
Drug: Copanlisib (Aliqopa, BAY80-6946)

Phase 3

Bayer
Bayer

Budapest, Hungary and 186 other locations

plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma...

Active, not recruiting
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Drug: Venetoclax
Drug: Obinutuzumab

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 40 other locations

This trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma....

Enrolling
Follicular Lymphoma (FL)
Drug: Lenalidomide and rituximab (R2) in 28-day cycles for up to 12 cycles.
Other: Corticosteroids and/or Radiation (Bridging therapy)

Phase 3

Novartis
Novartis

Budapest, Hungary and 27 other locations

A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma...

Enrolling
Diffuse Large B-cell Lymphoma
Drug: Selinexor

Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Budapest, Hungary and 175 other locations

Locations recently updated

The purpose of this study is to assess the efficacy and safety of of tafasitamab plus lenalidomide in adults with diffuse large B-cell lymphoma...

Enrolling
Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Lenalidomide
Drug: Tafasitamab

Phase 3

Incyte
Incyte

Budapest, Hungary and 60 other locations

The purpose of this study is to compare the efficacy and safety of pirtobrutinib (LOXO-305; Arm A) compared to BR (Arm B) in patients with CLL/SLL wh...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: Bendamustine

Phase 3

Loxo Oncology
Loxo Oncology

Székesfehérvár, Hungary and 107 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp...

Enrolling
Non-Hodgkin Lymphoma
Drug: Pirtobrutinib
Drug: Ibrutinib

Phase 2

Genmab
Genmab

Budapest, Hungary and 74 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems